Series C - NiKang Therapeutics - May 26, 2021 Funding Round Profile - Cointime

Bitcoin $79,574.24 +4.00%
Ethereum $3,205.09 +5.02%
BNB $635.57 +1.46%
Optimism $1.66 +1.06%
Arbitrum $0.64 +4.82%
Solana $205.35 +1.07%
Polygon $0.41 +5.46%
Cosmos $5.23 +9.62%
Avalanche $31.87 +7.75%

Bitcoin $79,574.24 +4.00%
Ethereum $3,205.09 +5.02%
BNB $635.57 +1.46%
Optimism $1.66 +1.06%
Arbitrum $0.64 +4.82%
Solana $205.35 +1.07%
Polygon $0.41 +5.46%
Cosmos $5.23 +9.62%
Avalanche $31.87 +7.75%

NiKang Therapeutics

company

Funding Round

Series C

Money Raised

$ 200M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail
Pavilion Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 14, 2020	Series B	$ 50M	Octagon Investments,Lilly Asia Ventures	Detail